Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 1595888 NEW YORK, NY
Back to ATNM Full portfolio

Position in ATNM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$34,127 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
13 quarters on record

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Derivatives in ATNM

reported options exposure · as of Jun 30, 2026
CallValue
$19,110
CallShares
19,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in ATNM

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,110 19,500
2026-03-31 $34,127 34,299
2026-03-31 $26,268 26,400
2025-12-31 $40,392 29,700
2025-12-31 $126,739 93,192
2025-09-30 $148,834 93,022
2025-06-30 $305,652 218,324
2024-09-30 $76,772 40,837
2024-06-30 $482,694 65,229
2024-03-31 $390,997 49,936
2023-12-31 $150,987 29,722
2023-06-30 $78,540 10,585
2023-03-31 $1,174,530 124,289
2022-12-31 $207,270 19,462
2020-03-31 $2,900 14,950